Vicore takes major step towards a clinical platform company targeting AT2R - new molecule ready for phase 1

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2...

Related Keywords

Sweden ,Gothenburg ,Vastra Gotalands Lan ,Vicore Pharma ,Carl Johan Dalsgaard ,Vicore Pharma Holding ,Johan Dalsgaard ,Pharma Holding ,Vicore Pharma Holding Ab ,